Anthropic's IPO Is Now at Risk — What the Fable 5 Government Ban Could Do to Its $965 Billion Valuation

On June 1, 2026, Anthropic confidentially submitted a draft registration statement to the Securities and Exchange Commission, setting the stage for what could become one of the largest technology IPOs in history. The filing came just days after the company closed a $65 billion funding round that pushed its valuation to $965 billion, briefly making it more valuable than rival OpenAI. Eleven days later, the US government ordered Anthropic to pull two of its newest AI models off the market entirely. For a company preparing to ask public investors to trust its growth story enough to buy shares, the timing could hardly have been more inconvenient, and the episode offers a useful, real-time lesson in a kind of risk that AI investors are only beginning to take seriously.

This article walks through what actually happened, what it reveals about the unusual position frontier AI companies occupy between government regulator and government customer, and what investors evaluating an eventual Anthropic IPO, or any AI company IPO, should honestly be thinking about as a result.

What Anthropic Actually Filed, and Why It Matters

Anthropic's confidential S-1 filing does not, by itself, commit the company to anything. A confidential submission allows a company to begin the SEC's review process privately, without disclosing detailed financials, risk factors or governance information to the public or to competitors. Anthropic has been explicit that the filing simply gives it the option to pursue a public listing once SEC review is complete, and that whether it actually proceeds will depend on market conditions and other factors. No share price, share count, ticker or listing date has been set.

What makes the filing significant regardless of those caveats is the scale and speed of the growth story behind it. Anthropic's annualized revenue run rate reportedly crossed $47 billion in May 2026, up from roughly $9 billion at the end of 2025, an extraordinary pace of expansion driven heavily by enterprise adoption of Claude and by Claude Code, the company's AI coding product. That growth helped justify the $965 billion valuation attached to the company's Series H round, a private-market figure that, if it holds into a public listing, would represent one of the largest debuts the technology sector has ever produced, alongside similarly historic offerings being prepared by SpaceX and OpenAI around the same time. It also means the company would be asking public market investors to pay a valuation implying roughly twenty times its current run-rate revenue, a multiple that public investors have not yet had the chance to test against audited financials, sustained profitability data, or a long track record as a publicly accountable company.

The Fable 5 Ban: What Happened and Why

The regulatory episode that has complicated this picture began on the evening of June 12, 2026, when Anthropic disclosed that it had received an export control directive from the US government, citing national security authorities, ordering it to suspend all access to two of its newest models, Claude Fable 5 and Claude Mythos 5, by any foreign national anywhere in the world, including the company's own non-citizen employees. Because there was no practical way to segment foreign-national users from everyone else on short notice across a customer base in the hundreds of millions, Anthropic disabled both models entirely, for every customer, while it worked through the dispute. The company stated that access to its other models, including Claude Opus 4.8, remained unaffected.

According to Anthropic's public account, the government's stated concern involved a method of bypassing, or jailbreaking, safeguards that had been built into Fable 5 specifically to limit its more advanced cybersecurity-related capabilities, which are drawn from the more powerful underlying Mythos model. Anthropic has said it reviewed the evidence it was given and concluded the jailbreak in question was narrow, non-universal, and capable of being replicated using other publicly available models not subject to the same export controls, including OpenAI's GPT-5.5. The company has publicly disagreed that this finding justified pulling a commercial model already deployed to hundreds of millions of users, while stating that it is complying with the directive and working to restore access. The government has not, according to Anthropic's account, provided detailed written documentation of the underlying concern. Both sides appear to be actively negotiating a path back to restored access, with reports suggesting the administration hopes Anthropic will address the safety issue so the export control can be lifted and Fable returned to general release.

A Company Caught Between Regulator and Customer

What makes Anthropic's situation distinctive, and instructive for understanding regulatory risk in the AI sector more broadly, is that the US government is not simply acting as Anthropic's regulator. It has also, at various points, been one of its most consequential customers and, separately, one of its most aggressive critics. Earlier in 2026, the Department of Defense designated Anthropic a supply chain risk, a label historically reserved for foreign adversaries, requiring the US military to stop using Claude models and barring defense contractors from using them in government-related work. That designation followed a breakdown in negotiations after Anthropic sought exemptions preventing its models from being used in autonomous weapons systems or mass domestic surveillance, terms the Pentagon's preferred contract language did not accommodate. Anthropic has sued the Trump administration in an effort to overturn the designation, and that litigation remains ongoing. President Trump told CNBC in April that a deal between Anthropic and the Defense Department remained possible, suggesting the dispute has not hardened into a permanent rupture, but no resolution had been reached as of the Fable 5 suspension in June.

This combination, a government that can simultaneously block a company's products from reaching its own defense customers, label that company a national security risk, and order an emergency worldwide suspension of its newest commercial product, represents a category of risk that is genuinely difficult to model using conventional investment analysis. Traditional regulatory risk in most industries tends to move relatively slowly, through rulemaking processes, public comment periods, and legislative debate. The actions affecting Anthropic in 2026 have moved in days, sometimes hours, driven by national security authorities that are not required to disclose detailed evidence and that can act before a company has any meaningful opportunity to respond. For a business preparing to ask public investors for capital, that unpredictability is not a footnote. It is arguably one of the central facts an investor needs to weigh.

How Investors Should Actually Think About This Risk

It would be a mistake to treat the Fable 5 suspension as evidence that Anthropic's underlying business is fundamentally broken. The company's revenue growth has, by every available account, continued accelerating even amid these regulatory disputes, and enterprise and consumer adoption of its other models appears to have kept climbing throughout the period when its relationship with parts of the federal government was at its most contentious. Reports indicate Anthropic expects to post its first profitable quarter around the same period, with second-quarter revenue projected to more than double from the prior three months. That is not the profile of a company in commercial decline.

What the episode does demonstrate, clearly and in real time, is that an investor evaluating Anthropic, or any frontier AI company, cannot treat regulatory and geopolitical risk as a minor risk-factor paragraph buried near the back of a prospectus. These risks are capable of materially affecting product availability, customer relationships, and government contract eligibility on short notice, and they are largely outside the company's direct control. A model that took years to develop and was deployed with what the company describes as thousands of hours of safety testing can be pulled from worldwide availability within a single business day based on a national security determination the company itself disputes. Investors comfortable with traditional technology-company risk, competitive pressure, execution risk, customer concentration, may find this particular flavor of risk considerably harder to price, precisely because it depends on the judgment and priorities of government officials rather than on competitive dynamics or engineering execution.

The most useful approach for an investor is not to treat this as a single, resolved verdict on whether Anthropic deserves its $965 billion valuation, but to recognize that the valuation now needs to account for a wider distribution of possible outcomes than it might have a few months ago. At one end of that distribution, the dispute over Fable 5 resolves relatively quickly, the DOD relationship is eventually repaired, and Anthropic's broader commercial momentum continues largely uninterrupted, supporting a valuation built primarily on its enterprise growth story. At the other end, continued friction with federal regulators constrains the company's ability to serve government and defense-adjacent customers, invites comparable scrutiny from international regulators watching how the US government treats its own frontier AI companies, and introduces a persistent valuation discount tied to political and national security risk that has little to do with product quality or customer demand. Where the true outcome lands between those two poles is something reasonable, well-informed people can currently disagree about, and that disagreement is itself useful information for anyone deciding how much of this risk they are willing to hold.

Is the $965 Billion Valuation Still Defensible?

The honest answer is that the valuation was always going to require investors to underwrite extraordinary execution, given that it implies roughly twenty times Anthropic's current revenue run rate in an industry where compute costs, talent competition, and the pace of model obsolescence are all unusually intense. That basic challenge has not changed because of the Fable 5 episode. What has changed is that investors now have a concrete, recent, real-world example of how quickly and unpredictably regulatory action can interrupt commercial availability of even Anthropic's most advanced products, and how entangled the company's fortunes have become with the shifting priorities of the federal government, as both a regulator with export control authority and a potential customer that has already shown a willingness to formally label the company a security risk.

None of this means the valuation is necessarily wrong. Extraordinary revenue growth, leading enterprise adoption, and genuine technical differentiation are real, demonstrated facts about Anthropic's business, not speculative claims. But a valuation built on twenty times revenue leaves very little room for the kind of disruption a sudden export control directive represents, and investors weighing a future IPO should treat the events of June 2026 not as a one-off curiosity, but as a preview of the kind of volatility that may recur as governments around the world continue working out, often in real time and without clear precedent, how to regulate companies building the most powerful AI systems in existence.

---

The Bottom Line

Anthropic's path toward a potential IPO was always going to be watched closely as a test of whether the AI sector's extraordinary private-market valuations can survive the scrutiny that comes with public markets. The Fable 5 suspension has added a second, related test: whether investors are willing to underwrite not just the commercial and competitive risks every technology company faces, but a distinctly modern form of regulatory risk in which a single national security determination can suspend access to a flagship product worldwide, with little warning and limited public explanation. Anthropic disputes the government's characterization of the underlying issue and says it is working to restore access. Whether that resolution comes quickly or drags on, and whether the broader relationship between Anthropic and federal regulators stabilizes or continues to deteriorate, will likely matter as much to the eventual success of its IPO as any single quarter of revenue growth.

*This article is for informational purposes only and does not constitute financial or investment advice. Always conduct your own research or consult a licensed financial advisor before making investment decisions. Data and statements referenced are sourced from CNBC, Fortune, TechCrunch, NPR, and Anthropic's public statements as of June 2026.*